This inventor holds 4 USPTO granted patents, plus 1 CIPO patent. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1993-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Sakai, JP (1993 - 1997)
- Osaka, JP (1997 - 2004)
Company Filing History:
Years Active: 1993-2004
Title: The Innovations of Yoshihiko Kaisho
Introduction
Yoshihiko Kaisho is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of biotechnology, particularly in the production of human nerve growth factors. With a total of 4 patents to his name, Kaisho's work has had a substantial impact on medical research and applications.
Latest Patents
Among his latest patents is a groundbreaking method for producing human nerve growth factor 2. This invention involves a transformant that harbors a recombinant vector containing a DNA sequence coding for human nerve growth factor 2, along with a DNA sequence coding for the pro-region of a nerve growth factor at the 5'-terminal of said DNA. This innovative approach allows for the stable and large-scale production of human nerve factor 2 in a culture medium, which is crucial for various therapeutic applications.
Career Highlights
Yoshihiko Kaisho is currently employed at Takeda Chemical Industries, Inc., a leading pharmaceutical company known for its commitment to research and development. His work at Takeda has enabled him to collaborate with other experts in the field, further enhancing the impact of his inventions.
Collaborations
Throughout his career, Kaisho has worked alongside notable colleagues such as Kazuo Nakahama and Koji Yoshimura. These collaborations have fostered a rich environment for innovation and have contributed to the advancement of their shared research goals.
Conclusion
Yoshihiko Kaisho's contributions to biotechnology, particularly in the area of nerve growth factors, highlight his role as a key inventor in the field. His innovative methods and collaborations continue to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
